Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS).

被引：0

作者：

Martin Broto, Javier

Silva Moura, David

Ramos, Rafael

Braglia, Luca

Collini, Paola

Renne, Salvatore L.

Romagosa, Cleofe

Coindre, Jean Michel

Velasco, Valerie

Merlo, Domenico F.

Palmerini, Emanuela

Stacchiotti, Silvia

Quagliuolo, Vittorio

Lopez-Pousa, Antonio

Grignani, Giovanni

Blay, Jean-Yves

Brunello, Antonella

Picci, Piero

Casali, Paolo Giovanni

Gronchi, Alessandro

机构：

[1] Univ Seville, Virgen del Rocio Univ Hosp, Inst Biomed Res IBIS, CSIC, Seville, Spain

[2] Univ Seville, Inst Biomed Seville, Grp Adv Therapies & Biomarkers Sarcomas, Ibis,Hosp Univ Virgen Del Rocio,CSIC, Seville, Spain

[3] Hosp Univ Son Espases, Palma de Mallorca, Spain

[4] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Clin Trial Ctr, Genoa, Italy

[5] IRCCS Azienda Osped Univ San Martino, IST Ist Nazl Ric Canc, Dept Epidemiol, Genoa, Italy

[6] Fdn IRCCS Ist Nazl Tumori, Dept Diagnost Pathol & Lab Med, Soft Tissue & Bone Pathol Histopathol & Pediat Pa, Milan, Italy

[7] Humanitas Res Hosp, Anat Pathol Unit, Milan, Italy

[8] H Vall dHebron, Barcelona, Spain

[9] Inst Bergonie, Bordeaux, France

[10] Inst Bergonie, Dept Pathol, Bordeaux, France

[11] IRCCS Ist Ortoped Rizzoli, Bologna, Italy

[12] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[13] Ist Clin Humanitas, Milan, Italy

[14] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[15] FPO IRCCS, Candiolo Canc Inst, Div Med Oncol, Candiolo, TO, Italy

[16] UNICANCER, Ctr Leon Berard, Lyon, France

[17] Ist Oncol Veneto IRCCS, Med Oncol Unit 1, Clin & Expt Oncol Dept, Padua, Italy

[18] Italian Sarcoma Grp, Bologna, Italy

[19] Fdn IRCCS Ist Nazl Tumori, Dept Canc Med, Adult Mesenchymal & Rare Tumor Unit, Milan, Italy

[20] Fdn IRCCS Ist Nazl Tumori, Dept Surg, Sarcoma Serv, Milan, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期

基金：

欧洲研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1001

引用

页数：2

共 50 条

[21] Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial.
Stacchiotti, Silvia
Verderio, Paolo
Messina, Antonella
Morosi, Carlo
Collini, Paola
Llombart-Bosch, Antonio
Broto, Javier Martin
Comandone, Alessandro
Crur, Josefina
Ferrari, Stefano
Grignani, Giovanni
Bottelli, Stefano
Quagliuolo, Vittorio
Picci, Piero
De Paoli, Antonino
Dei Tos, Angelo Paolo
Casali, Paolo Giovanni
Gronchi, Alessandro
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[22] SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
Elizabeth J. Davis
Lili Zhao
David R. Lucas
Scott M. Schuetze
Laurence H. Baker
Mark M. Zalupski
Dafydd Thomas
Rashmi Chugh
BMC Cancer, 16
[23] SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
Davis, Elizabeth J.
Zhao, Lili
Lucas, David R.
Schuetze, Scott M.
Baker, Laurence H.
Zalupski, Mark M.
Thomas, Dafydd
Chugh, Rashmi
BMC CANCER, 2016, 16
[24] Prognostic/predictive biomarkers in advanced soft tissue sarcomas (STS): Translational research associated to randomized phase II trial comparing trabectedin-doxorubicin versus doxorubicin-A GEIS study.
Martin Broto, Javier
Martinez-Serra, Jorge
Ramos, Rafael
Antonio Lopez-Guerrero, Jose
Bague, Silvia
Martinez, Carmen
Alvarez, Ramiro
Garcia del Muro, Xavier
De Las Penas, Ramon
Gutierrez, Antonio
Martinez-Trufero, Javier
Cruz, Josefina
Poveda, Andres
Maria Alvarez, Rosa
Cubedo, Ricardo
Redondo, Andrs
Maurel, Juan Oppor
Angeles Sala, Maria
Lopez-Martin, Jose A.
Lopez-Pousa, Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[25] Relationship of CUL4A gene underexpression and prognosis in localized high-risk soft tissue sarcoma (STS) patients of limbs or trunk wall.
Broto, Javier Martin
Lopez-Pousa, Antonio
Ramos, Rafael
Gronchi, Alessandro
Casali, Paolo Giovanni
Gutierrez, Antonio
Picci, Piero
Ferrari, Stefano
Cruz, Josefina
Fra, Pablo Luna
Casado, Antonio
Cubedo, Ricardo
Lasso, Roberto
Poveda, Andres
De Juan, Ana
Balana, Carmen
Calabuig, Silvia
Obrador, Antonia
Lopez-Guerrero, Jose Antonio
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[26] Neo/adjuvant doxorubicin (A) and ifosfamide (I) versus gemcitabine (G) and docetaxel (T) in patients (PTS) with localized, high risk soft tissue sarcoma (STS): A randomized phase II comparative effectiveness trial.
Davis, Elizabeth J.
Chugh, Rashmi
Zhao, Lili
Biermann, J. Sybil
Wong, Sandra L.
Feng, Mary Uan-Sian
Lucas, David Robert
Featherstone, D'Andra
Reinke, Denise
Zalupski, Mark M.
Schuetze, Scott
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[27] NEO-ADJUVANT CHEMOTHERAPY WITH REGIONAL HYPERTHERMIA (RHT)FOR LOCALIZED HIGH-RISK SOFT-TISSUE SARCOMA (HR-STS) WITH ABDOMINAL/RETROPERITONEAL LOCATION
Issels, R. D.
Lindner, L. H.
Reichardt, P.
Schem, B.
Wendtner, C.
Wessalowski, R.
Jauch, K.
Mansmann, U.
Blay, J.
Hohenberger, P.
ANNALS OF ONCOLOGY, 2010, 21 : 411 - 411
[28] Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study
Issels, R. D.
Lindner, L. H.
Ghadjar, P.
Reichardt, P.
Hohenberger, P.
Verweij, J.
Abdel-Rahman, S.
Daugaard, S.
Salat, C.
Vujaskovic, Z.
Wessalowski, R.
Duerr, H. R.
Ploner, F.
Mella, O.
Schmidt, M.
Mansmann, U.
Jauch, K. W.
Belka, C.
Hiddemann, W.
Gronchi, A.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S716 - S716
[29] Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial (vol 18, pg 812, 2017)
Gronchi, A.
Ferrari, S.
Quagliuolo, V
LANCET ONCOLOGY, 2017, 18 (06): : E301 - E301
[30] Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group
Gronchi, A.
Stacchiotti, S.
Verderio, P.
Ferrari, S.
Broto, J. Martin
Lopez-Pousa, A.
Llombart-Bosch, A.
Tos, A. P. Dei
Collini, P.
Cruz Jurado, J.
De Paoli, A.
Donati, D. M.
Poveda, A.
Quagliuolo, V.
Comandone, A.
Grignani, G.
Morosi, C.
Messina, A.
De Sanctis, R.
Bottelli, S.
Palassini, E.
Casali, P. G.
Picci, Piero
ANNALS OF ONCOLOGY, 2016, 27 (12) : 2283 - 2288

← 1 2 3 4 5 →